Objective: This study explores whether hyaluronic acid (HA) of different molecular weights and collagen, given their role in tendon extracellular matrix maintenance, have a synergistic effect on human tendon-derived cells, with the aim to improve the treatment of tendinopathy.
Material: Human monocytes (CRL-9855™) and primary Achilles tendon-derived cells.
Treatment: The collagen/HA ratio was based on the formulation of the commercial food supplement TendoGenIAL™. The anti-inflammatory activity was evaluated on human lipopolysaccharide (LPS)-stimulated macrophages (24 h) or human Achilles tendon-derived cells under basal and pro-inflammatory conditions (24 and 72 h) and on a co-culture model of tenocytes and inflamed macrophages (24 h).
Results: These data show that the combination of high molecular weight hyaluronic acid and collagen reduces inflammation in macrophages by downregulating CD14, with a mean fluorescence intensity (MFI) of 36,274 (± 1780) (p < 0.0001). Additionally, this combination enhances the modulation of extracellular matrix remodeling proteins, such as CD44 whose MFI is 675,435 (± 28109) (p < 0.00001) and collagen type I at 17.838 µg/mL (± 6,259) (p < 0.00001). The observation of the ultrastructure of tenocytes through electron microscopy reveals increased cell membrane vesiculation and cell size, indicating that tenocytes start to proliferate and create abundant extracellular matrix proteins, important for the matrix remodeling.
Conclusions: Our data confirm the anti-inflammatory activity of both hyaluronic acids and collagen, highlighting a synergistic effect of their combination in a determined ratio.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00011-024-01975-5 | DOI Listing |
Inflamm Res
January 2025
Department of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, 66100, Chieti, Italy.
Objective: This study explores whether hyaluronic acid (HA) of different molecular weights and collagen, given their role in tendon extracellular matrix maintenance, have a synergistic effect on human tendon-derived cells, with the aim to improve the treatment of tendinopathy.
Material: Human monocytes (CRL-9855™) and primary Achilles tendon-derived cells.
Treatment: The collagen/HA ratio was based on the formulation of the commercial food supplement TendoGenIAL™.
J Orthop Res
February 2025
Department of Orthopaedic Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Heterotopic ossification (HO) in Achilles tendon often arises due to endochondral ossification during the healing process following trauma. Retinoic acid receptor γ (RARγ) plays a critical role in this phenomenon. This study aims to elucidate the therapeutic effects of CD1530, an RARγ selective agonist, along with the contributing cells, in Achilles tendon healing, utilizing a cell lineage tracing system.
View Article and Find Full Text PDFJ Orthop Res
January 2025
Department of Orthopedic Surgery, National Defense Medical College, Saitama, Japan.
J Orthop Translat
July 2024
Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
Objectives: Excessive inflammation contributes to the pathogenesis of tendinopathy. Fatty acid binding protein 4 (FABP4) is a pro-inflammatory adipokine mediating various metabolic and inflammatory diseases. This study aimed to examine the expression of FABP4 and its association with the expressions of inflammatory cytokines in tendinopathy.
View Article and Find Full Text PDFACS Appl Bio Mater
July 2024
Center for Materials Synthetic Biology, CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!